marlborough pharmaceuticals limited

marlborough pharmaceuticals limited Company Information

Share MARLBOROUGH PHARMACEUTICALS LIMITED
Live 
MatureMicroDeclining

Company Number

05339752

Industry

Other business support service activities n.e.c.

 

Directors

Amit Patel

Neeshe Williams

View All

Shareholders

atnahs pharma uk limited

Group Structure

View All

Contact

Registered Address

sovereign house miles gray road, basildon, essex, SS14 3FR

marlborough pharmaceuticals limited Estimated Valuation

£36.1k

Pomanda estimates the enterprise value of MARLBOROUGH PHARMACEUTICALS LIMITED at £36.1k based on a Turnover of £4k and 9.02x industry multiple (adjusted for size and gross margin).

marlborough pharmaceuticals limited Estimated Valuation

£0

Pomanda estimates the enterprise value of MARLBOROUGH PHARMACEUTICALS LIMITED at £0 based on an EBITDA of £-306k and a 66.51x industry multiple (adjusted for size and gross margin).

marlborough pharmaceuticals limited Estimated Valuation

£59.9m

Pomanda estimates the enterprise value of MARLBOROUGH PHARMACEUTICALS LIMITED at £59.9m based on Net Assets of £25.5m and 2.35x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Marlborough Pharmaceuticals Limited Overview

Marlborough Pharmaceuticals Limited is a live company located in essex, SS14 3FR with a Companies House number of 05339752. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in January 2005, it's largest shareholder is atnahs pharma uk limited with a 100% stake. Marlborough Pharmaceuticals Limited is a mature, micro sized company, Pomanda has estimated its turnover at £4k with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Marlborough Pharmaceuticals Limited Health Check

Pomanda's financial health check has awarded Marlborough Pharmaceuticals Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating1.5out of 5
positive_score

2 Strong

positive_score

0 Regular

positive_score

7 Weak

size

Size

annual sales of £4k, make it smaller than the average company (£3.1m)

£4k - Marlborough Pharmaceuticals Limited

£3.1m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -94%, show it is growing at a slower rate (4.1%)

-94% - Marlborough Pharmaceuticals Limited

4.1% - Industry AVG

production

Production

with a gross margin of 1275%, this company has a lower cost of product (38.5%)

1275% - Marlborough Pharmaceuticals Limited

38.5% - Industry AVG

profitability

Profitability

an operating margin of -11175% make it less profitable than the average company (6.5%)

-11175% - Marlborough Pharmaceuticals Limited

6.5% - Industry AVG

employees

Employees

with 1 employees, this is below the industry average (20)

1 - Marlborough Pharmaceuticals Limited

20 - Industry AVG

paystructure

Pay Structure

There is insufficient data available for this Key Performance Indicator!

- - Marlborough Pharmaceuticals Limited

- - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £4k, this is less efficient (£141.2k)

£4k - Marlborough Pharmaceuticals Limited

£141.2k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 730 days, this is later than average (40 days)

730 days - Marlborough Pharmaceuticals Limited

40 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after -77 days, this is quicker than average (34 days)

-77 days - Marlborough Pharmaceuticals Limited

34 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Marlborough Pharmaceuticals Limited

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Marlborough Pharmaceuticals Limited

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 1.6%, this is a lower level of debt than the average (60.6%)

1.6% - Marlborough Pharmaceuticals Limited

60.6% - Industry AVG

MARLBOROUGH PHARMACEUTICALS LIMITED financials

EXPORTms excel logo

Marlborough Pharmaceuticals Limited's latest turnover from March 2023 is £4 thousand and the company has net assets of £25.5 million. According to their latest financial statements, we estimate that Marlborough Pharmaceuticals Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Jan 2011Jan 2010
Turnover4,0005,375,00010,844,00015,424,37116,113,63617,072,52318,053,82615,814,4897,443,8603,395,3689,950,8136,933,2814,611,5793,309,716
Other Income Or Grants00000000000000
Cost Of Sales-47,0001,041,000551,0001,218,9321,241,1311,170,6171,405,3071,619,9081,587,8502,112,6096,302,9114,273,7892,779,3691,998,916
Gross Profit51,0004,334,00010,293,00014,205,43914,872,50515,901,90616,648,51914,194,5815,856,0101,282,7593,647,9022,659,4931,832,2101,310,800
Admin Expenses498,0001,956,0004,965,0006,485,9816,798,6877,303,5847,321,7316,260,0961,323,520888,3483,770,6452,711,2471,672,1441,031,143
Operating Profit-447,0002,378,0005,328,0007,719,4588,073,8188,598,3229,326,7887,934,4854,532,490394,411-122,743-51,754160,066279,657
Interest Payable0000014300000000
Interest Receivable451,000037,00056769610,19624,51828,45502,8544,8073,0161,064
Pre-Tax Profit4,0002,378,0005,365,0007,767,9028,103,4528,596,8969,336,4267,957,1594,560,945395,058-119,889-46,947163,082280,721
Tax-22,000-84,000-204,000-1,150-1,523,167-1,539,554-1,829,473-1,708,027-384,450000-45,663-78,602
Profit After Tax-18,0002,294,0005,161,0007,766,7526,580,2857,057,3427,506,9536,249,1324,176,495395,058-119,889-46,947117,419202,119
Dividends Paid000005,500,00015,370,5501,003,868000000
Retained Profit-18,0002,294,0005,161,0007,766,7526,580,2851,557,342-7,863,5975,245,2644,176,495395,058-119,889-46,947117,419202,119
Employee Costs000000002,063,289952,5002,782,2511,943,1171,326,946883,718
Number Of Employees14392122127138151124582780563722
EBITDA*-306,0002,687,0007,098,0007,736,4588,073,8188,598,3229,643,1488,286,1794,891,120615,841128,800199,789160,066279,657

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Jan 2011Jan 2010
Tangible Assets187,000205,000411,000161,81246,07846,07844,0980000000
Intangible Assets3,303,0003,352,0003,216,0001,709,8741,024,623749,489222,965316,360668,054867,4261,046,9141,298,4571,550,0001,550,000
Investments & Other000000000480,000480,000480,00000
Debtors (Due After 1 year)000000000000033,704
Total Fixed Assets3,490,0003,557,0003,627,0001,871,6861,070,701795,567267,063316,360668,0541,347,4261,526,9141,778,4571,550,0001,583,704
Stock & work in progress0128,000808,000431,028381,485315,516417,532537,705662,429317,953711,404400,043288,270249,936
Trade Debtors8,00076,0001,800,0003,001,04003,358,2331,671,3271,841,1711,784,862506,576965,951494,407352,615277,870
Group Debtors22,356,00022,337,00017,977,00017,661,98517,912,2206,113,9142,095,4406,330,284000000
Misc Debtors55,00011,0002,00013,3371,205,263000491,32200000
Cash0001,7477,21224,0701,276,4728,749,9222,402,760145,91601,141,749781,016425,522
misc current assets00000000000000
total current assets22,419,00022,552,00020,587,00021,109,13719,506,1809,811,7335,460,77117,459,0825,341,373970,4451,677,3552,036,1991,421,901953,328
total assets25,909,00026,109,00024,214,00022,980,82320,576,88110,607,3005,727,83417,775,4426,009,4272,317,8713,204,2693,814,6562,971,9012,537,032
Bank overdraft00000000000000
Bank loan00000000000000
Trade Creditors 10,0000138,000119,18322,763141,05461,9495,05299,5361,428,9431,957,4761,943,3461,355,359893,604
Group/Directors Accounts0003,453,2573,097,1262,622,3452,098,1845,694,577234,53800000
other short term finances00000000000000
hp & lease commitments00000000000000
other current liabilities395,000631,000892,0001,385,6407,201,0014,168,1931,449,3352,093,850938,65400000
total current liabilities405,000631,0001,030,0004,958,08010,320,8906,931,5923,609,4687,793,4791,272,7281,428,9431,957,4761,943,3461,355,359893,604
loans00000000000000
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities000000000328,7241,082,0871,236,715935,0001,079,305
provisions00000000000000
total long term liabilities000000000328,7241,082,0871,236,715935,0001,079,305
total liabilities405,000631,0001,030,0004,958,08010,320,8906,931,5923,609,4687,793,4791,272,7281,757,6673,039,5633,180,0612,290,3591,972,909
net assets25,504,00025,478,00023,184,00018,022,74310,255,9913,675,7082,118,3669,981,9634,736,699560,204164,706634,595681,542564,123
total shareholders funds25,460,00025,478,00023,184,00018,022,74310,255,9913,675,7082,118,3669,981,9634,736,699560,204164,706634,595681,542564,123
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Jan 2011Jan 2010
Operating Activities
Operating Profit-447,0002,378,0005,328,0007,719,4588,073,8188,598,3229,326,7887,934,4854,532,490394,411-122,743-51,754160,066279,657
Depreciation41,000209,0002,00000000000000
Amortisation100,000100,0001,768,00017,00000316,360351,694358,630221,430251,543251,54300
Tax-22,000-84,000-204,000-1,150-1,523,167-1,539,554-1,829,473-1,708,027-384,450000-45,663-78,602
Stock-128,000-680,000376,97249,54365,969-102,016-120,173-124,724344,476-393,451311,361111,77338,334249,936
Debtors-5,0002,645,000-897,3621,558,8799,645,3365,705,380-4,404,6885,895,2711,769,608-459,375471,544141,79241,041311,574
Creditors10,000-138,00018,81796,420-118,29179,10556,897-94,484-1,329,407-528,53314,130587,987461,755893,604
Accruals and Deferred Income-236,000-261,000-493,640-5,815,3613,032,8082,718,858-644,5151,155,196938,65400000
Deferred Taxes & Provisions00000000000000
Cash flow from operations-421,000239,0006,939,567407,945-246,1374,253,36711,750,9181,868,3172,001,833940,134-639,975534,211496,783533,149
Investing Activities
capital expenditure-74,000-239,000-3,525,314-817,985-275,134-528,504-267,0630-159,258-41,942000-1,550,000
Change in Investments00000000-480,00000480,00000
cash flow from investments-74,000-239,000-3,525,314-817,985-275,134-528,504-267,0630320,742-41,9420-480,0000-1,550,000
Financing Activities
Bank loans00000000000000
Group/Directors Accounts00-3,453,257356,131474,781524,161-3,596,3935,460,039234,53800000
Other Short Term Loans 00000000000000
Long term loans00000000000000
Hire Purchase and Lease Commitments00000000000000
other long term liabilities00000000-328,724-753,363-154,628301,715-144,3051,079,305
share issue002570-20000440-350,00000362,004
interest451,000037,00056769-13710,19624,51828,45502,8544,8073,0161,064
cash flow from financing451,0000-3,416,000356,187475,548524,024-3,586,1975,484,557-65,731-752,923-501,774306,522-141,2891,442,373
cash and cash equivalents
cash00-1,747-5,465-16,858-1,252,402-7,473,4506,347,1622,256,844145,916-1,141,749360,733355,494425,522
overdraft00000000000000
change in cash00-1,747-5,465-16,858-1,252,402-7,473,4506,347,1622,256,844145,916-1,141,749360,733355,494425,522

marlborough pharmaceuticals limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for marlborough pharmaceuticals limited. Get real-time insights into marlborough pharmaceuticals limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Marlborough Pharmaceuticals Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for marlborough pharmaceuticals limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other micro companies, companies in SS14 area or any other competitors across 12 key performance metrics.

marlborough pharmaceuticals limited Ownership

MARLBOROUGH PHARMACEUTICALS LIMITED group structure

Marlborough Pharmaceuticals Limited has 1 subsidiary company.

Ultimate parent company

TRITON MANAGERS V LTD

#0131704

2 parents

MARLBOROUGH PHARMACEUTICALS LIMITED

05339752

1 subsidiary

MARLBOROUGH PHARMACEUTICALS LIMITED Shareholders

atnahs pharma uk limited 100%

marlborough pharmaceuticals limited directors

Marlborough Pharmaceuticals Limited currently has 6 directors. The longest serving directors include Mr Amit Patel (Aug 2019) and Mrs Neeshe Williams (Aug 2019).

officercountryagestartendrole
Mr Amit PatelUnited Kingdom46 years Aug 2019- Director
Mrs Neeshe WilliamsUnited Kingdom43 years Aug 2019- Director
Amit PatelUnited Kingdom46 years Aug 2019- Director
Felipe FlorezSwitzerland48 years Jun 2021- Director
Mr James BurtUnited Kingdom50 years Dec 2021- Director
Mr Santsagar PatelUnited Kingdom51 years Jun 2024- Director

P&L

March 2023

turnover

4k

-100%

operating profit

-447k

-119%

gross margin

1275%

+1481.25%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

25.5m

0%

total assets

25.9m

-0.01%

cash

0

0%

net assets

Total assets minus all liabilities

marlborough pharmaceuticals limited company details

company number

05339752

Type

Private limited with Share Capital

industry

82990 - Other business support service activities n.e.c.

incorporation date

January 2005

age

20

incorporated

UK

ultimate parent company

TRITON MANAGERS V LTD

accounts

Total Exemption Full

last accounts submitted

March 2023

previous names

marlborough phamaceuticals limited (February 2005)

accountant

-

auditor

-

address

sovereign house miles gray road, basildon, essex, SS14 3FR

Bank

-

Legal Advisor

-

marlborough pharmaceuticals limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 7 charges/mortgages relating to marlborough pharmaceuticals limited. Currently there are 5 open charges and 2 have been satisfied in the past.

marlborough pharmaceuticals limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MARLBOROUGH PHARMACEUTICALS LIMITED. This can take several minutes, an email will notify you when this has completed.

marlborough pharmaceuticals limited Companies House Filings - See Documents

datedescriptionview/download